NYSE:CVS - CVS Health Stock Price, News, & Analysis

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health declared a quarterly dividend on Thursday, January 3rd. Shareholders of record on Friday, January 25th will be paid a dividend of $0.50 per share on Monday, February 4th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 3.11%. The ex-dividend date of this dividend is Thursday, January 24th. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) released its earnings results on Tuesday, November, 6th. The pharmacy operator reported $1.73 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.71 by $0.02. The pharmacy operator earned $47.27 billion during the quarter, compared to analysts' expectations of $47.22 billion. CVS Health had a net margin of 1.65% and a return on equity of 18.69%. The company's revenue for the quarter was up 2.4% on a year-over-year basis. During the same period last year, the company posted $1.50 EPS. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Thursday, February 14th 2019. View Earnings Estimates for CVS Health.

CVS Health will be holding an earnings conference call on Wednesday, February 20th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

CVS Health updated its FY18 earnings guidance on Tuesday, November, 6th. The company provided earnings per share (EPS) guidance of $6.98-7.08 for the period, compared to the Thomson Reuters consensus EPS estimate of $7.04. CVS Health also updated its FY 2018 guidance to $6.98-7.08 EPS.

17 equities research analysts have issued 1-year price targets for CVS Health's stock. Their forecasts range from $80.00 to $104.00. On average, they anticipate CVS Health's stock price to reach $92.9375 in the next year. This suggests a possible upside of 44.6% from the stock's current price. View Analyst Price Targets for CVS Health.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 3 hold ratings and 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

Media coverage about CVS stock has been trending positive recently, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of media coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. CVS Health earned a daily sentiment score of 2.8 on InfoTrie's scale. They also assigned headlines about the pharmacy operator a news buzz of 7.0 out of 10, indicating that recent media coverage is likely to have an impact on the company's share price in the immediate future.

CVS Health saw a decrease in short interest in December. As of December 14th, there was short interest totalling 11,357,418 shares, a decrease of 67.7% from the November 30th total of 35,182,217 shares. Based on an average daily trading volume, of 12,090,071 shares, the days-to-cover ratio is presently 0.9 days. Currently, 0.9% of the shares of the company are short sold. View CVS Health's Current Options Chain.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Express Scripts (ESRX), Diplomat Pharmacy (DPLO), Rite Aid (RAD), 111 (YI), Petmed Express (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

CVS Health's stock is owned by a number of of retail and institutional investors. Top institutional investors include Retirement Systems of Alabama (0.13%), Hexavest Inc. (0.13%), Factory Mutual Insurance Co. (0.08%), Gateway Investment Advisers LLC (0.08%), Alta Capital Management LLC (0.06%) and Cacti Asset Management LLC (0.04%). Company insiders that own CVS Health stock include Andrew Sussman, C David Brown II, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including DNB Asset Management AS, Factory Mutual Insurance Co., Alta Capital Management LLC, Gulf International Bank UK Ltd, Endurance Wealth Management Inc., Legacy Advisors LLC, Altfest L J & Co. Inc. and Edge Wealth Management LLC. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Eva C Boratto, Helena Foulkes, Kevin Hourican, Larry J Merlo, Lisa Bisaccia and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was bought by a variety of institutional investors in the last quarter, including Gateway Investment Advisers LLC, KAMES CAPITAL plc, Retirement Systems of Alabama, Chesley Taft & Associates LLC, State of Alaska Department of Revenue, Virtu Financial LLC, Taylor Wealth Management Partners and Beech Hill Advisors Inc.. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $64.27.

CVS Health has a market capitalization of $66.57 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $5.90 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

The official website for CVS Health is http://www.cvshealth.com.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]